Clinical and translational results of a phase I study, tocilizumab plus gemcitabine/nab-paclitaxel in patient with gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer

被引：0
|
作者：
Mitsunaga, Shuichi [1 ]
Ikeda, Masafumi [1 ]
Aoki, Kazunori [2 ]
Yamaguchi, Kyoko [3 ]
Sawada, Noriaki [4 ]
Fujii, Etsuko [4 ]
Nishidate, Masanobu [4 ]
Fujitomo, Takashi [4 ]
Mizuno, Hideaki [4 ]
Kayukawa, Yoko [4 ]
Kato, Atsuhiko [5 ]
Makikawa, Mayu [3 ]
Imaoka, Hiroshi [1 ]
Sasaki, Mitsuhito [1 ]
Watanabe, Kazuo [1 ]
Tsunoda, Hiroyuki [4 ]
Terao, Kimio [3 ]
Ochiai, Atsushi [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Chugai Pharmaceut Co Ltd, Tokyo, Japan
[4] Chugai Pharmaceut Co Ltd, Kamakura, Kanagawa, Japan
[5] Chugai Pharmaceut Co Ltd, Shizuoka, Japan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT565
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Gemcitabine and nab-paclitaxel combination therapy for the treatment of metastatic pancreatic cancer
    Sasaki, Takashi
    Kanata, Ryo
    Saito, Kei
    Yamada, Ikuhiro
    Matsuyama, Masato
    Ozaka, Masato
    Takano, Kouichi
    Sasahira, Naoki
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
    Kamata, Ken
    Imai, Hajime
    Matsumoto, Hisakazu
    Yamashita, Yukitaka
    Kato, Takao
    Nishi, Katsuhisa
    Omoto, Shunsuke
    Minaga, Kosuke
    Yamao, Kentaro
    Hyodo, Tomoko
    Im, Sung-Woon
    Hara, Akane
    Yoshikawa, Tomoe
    Ishikawa, Rei
    Okamoto, Ayana
    Yamazaki, Tomohiro
    Nakai, Atsushi
    Ueshima, Kazuomi
    Chiba, Yasutaka
    Takenaka, Mamoru
    Watanabe, Tomohiro
    Kitano, Masayuki
    Kudo, Masatoshi
    JGH OPEN, 2023, 7 (09): : 659 - 666
  • [33] Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study
    Rivera, Fernando
    Benavides, Manuel
    Gallego, Javier
    Guillen-Ponce, Carmen
    Lopez-Martin, Jose
    Kung, Marc
    PANCREATOLOGY, 2019, 19 (01) : 64 - 72
  • [34] Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    Imaoka, Hiroshi
    Sasaki, Mitsuhito
    Watanabe, Kazuo
    Sato, Akihiro
    Aoki, Kazunori
    Ochiai, Atsushi
    Makikawa, Mayu
    Nishidate, Masanobu
    Yamaguchi, Kyoko
    Terao, Kimio
    Sawada, Noriaki
    Fujitomo, Takashi
    Fujii, Etsuko
    Kato, Atsuhiko
    Tsunoda, Hiroyuki
    CANCER SCIENCE, 2023, 114 (10) : 4006 - 4019
  • [35] Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study
    Catalano, Martina
    Roviello, Giandomenico
    Conca, Raffaele
    D'Angelo, Alberto
    Palmieri, Valeria Emma
    Panella, Benedetta
    Petrioli, Roberto
    Ianza, Anna
    Nobili, Stefania
    Mini, Enrico
    Ramello, Monica
    CURRENT CANCER DRUG TARGETS, 2020, 20 (11) : 887 - 895
  • [36] A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study
    Nakazawa, J.
    Otsuka, T.
    Shimokawa, M.
    Koga, F.
    Ueda, Y.
    Otsu, S.
    Arima, S.
    Fukahori, M.
    Makiyama, A.
    Taguchi, H.
    Honda, T.
    Shibuki, T.
    Shirakawa, T.
    Mitsugi, K.
    Nio, K.
    Ide, Y.
    Ureshino, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Waypa, Jordan
    Coats, Jessica
    Blaydorn, Lisa
    McGahey, Kayla
    Sangal, Ashish
    Whitehead, Robert P.
    Khemka, Vivek
    CANCER RESEARCH, 2017, 77
  • [38] Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
    Chen, Shuling
    Li, Jiaxin
    Dong, Aoran
    Liu, Zelong
    Zhu, Meiyan
    Jin, Meng
    Wei, Guangyan
    Wu, Shuang
    Wang, Yan
    Chen, Yong
    Peng, Zhenwei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [39] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
    Shuling Chen
    Jiaxin Li
    Aoran Dong
    Zelong Liu
    Meiyan Zhu
    Meng Jin
    Guangyan Wei
    Shuang Wu
    Yan Wang
    Yong Chen
    Zhenwei Peng
    Journal of Hematology & Oncology, 16
12345